WealthPLAN Partners LLC Lowers Position in Danaher Co. (NYSE:DHR)

WealthPLAN Partners LLC reduced its holdings in Danaher Co. (NYSE:DHR) by 19.4% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,993 shares of the conglomerate’s stock after selling 2,166 shares during the quarter. WealthPLAN Partners LLC’s holdings in Danaher were worth $2,064,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in DHR. Heck Capital Advisors LLC purchased a new position in shares of Danaher during the fourth quarter worth about $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher during the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC purchased a new stake in shares of Danaher during the 4th quarter valued at $31,000. Teachers Insurance & Annuity Association of America purchased a new stake in shares of Danaher during the 3rd quarter valued at $39,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in shares of Danaher during the 3rd quarter valued at $40,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Up 1.5 %

Shares of NYSE DHR opened at $206.66 on Friday. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a fifty day simple moving average of $230.00 and a two-hundred day simple moving average of $249.96. The firm has a market capitalization of $149.26 billion, a PE ratio of 39.14, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the business posted $2.09 EPS. Equities analysts expect that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.52%. Danaher’s dividend payout ratio (DPR) is 20.45%.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of research analyst reports. Barclays reduced their target price on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Citigroup dropped their target price on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 30th. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Royal Bank of Canada reissued an “outperform” rating and set a $277.00 price target (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Finally, UBS Group reduced their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $278.00.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.